Table 2.
Major bleeding complications of patients with and without diabetes
| Event | Total patients (N = 76,302) | Patients without diabetes (n = 68,057) | Patients with diabetes (n = 8245) | P value |
|---|---|---|---|---|
| Major bleeding complications, n (%) | 678 (0.9) | 424 (0.6) | 254 (3.1) | <0.001 |
| RBC transfusion, n (%) | 622 (0.8) | 381 (0.6) | 241 (2.9) | <0.001 |
| Invasive hemostasis, n (%) | 109 (0.1) | 82 (0.1) | 27 (0.3) | <0.001 |
| Massive RBC transfusion, n (%) | 201 (0.3) | 70 (0.1) | 131 (1.6) | <0.001 |
RBC, red blood cell.
Some patients received both RBC transfusion and invasive hemostasis. Thus, they were not mutually exclusive.